loratadine, Claritin, Claritin RediTabs, Alavert, others
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: loratadine
BRAND NAME: Claritin, Claritin RediTabs, Alavert, others
DRUG CLASS AND MECHANISM: Loratadine is a long-acting antihistamine that is used for the treatment of allergy. Histamine is a chemical that causes many signs and symptoms of allergy. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine on their surfaces. Histamine stimulates the cells to release chemicals that produce effects that we associate with allergy. Loratadine blocks one type of histamine receptor (the H1 receptor) and thus prevents activation of cells with H1 receptors by histamine. Unlike some antihistamines, loratadine does not enter the brain from the blood and, therefore, does not cause drowsiness when taken at recommended doses. The FDA approved loratadine in April 1993.
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets: 10 mg. Tablets, disintegrating: 5 and 10 mg. Tablets, chewable: 10 mg. Syrup: 5 mg/5 ml.
STORAGE: Tablets should be stored between 2°-30°C (36°-86°F), and syrup should be stored between 2°-25°C (36°-77°F).
PRESCRIBED FOR: Loratadine is used for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis. It is also used to treat patients with chronic urticaria, a type of allergic skin rash.
DOSING: The usual dose of loratadine is 10 mg daily for adults and children older than six years of age.
DRUG INTERACTIONS: Erythromycin, cimetidine (Tagamet), and ketoconazole (Nizoral) increase the blood concentration of loratadine by inhibiting the elimination of loratadine. This may result in increased adverse events from loratadine.
PREGNANCY: There are no adequate studies of loratadine in pregnant women. Loratidine should be used during pregnancy only if it is clearly needed.
NURSING MOTHERS: Loratadine is secreted in breast milk at levels similar to blood levels. Nursing mothers should decide whether to stop breastfeeding or discontinue loratadine.
Reference: FDA Prescribing Information
Last Editorial Review: 4/14/2008
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index